Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesUnsuspected Pulmonary Embolism in Observation Unit Patients
Western Journal of Emergency Medicine, 09/02/09
Limkakeng AT et al. – The authors identified a small number of patients assigned to observation with unsuspected PE. The high rate of hospital admission and prolonged hospital stay suggests that patients with PE are inappropriate for observation status. Given the low incidence of unsuspected PE, there may be a need for a specific approach to screening for PE in observation unit patients.
Related Articles
Regional Immunity of the Eye
Acta Ophthalmologica, 11/13/09
Relevance Score: 91%
Use of bisphosphonates and raloxifene and risk of deep venous thromboembolism and pulmonary embolism
Osteoporosis International, 10/30/09
Relevance Score: 89%
Retinol binding protein 4 - a novel association with early-onset preeclampsia
Journal of Perinatal Medicine, 10/01/09
Relevance Score: 89%
Role of nutrition in the risk of preeclampsia
Nutrition Reviews, 11/10/09
Relevance Score: 87%
Genetic and environmental effects on the continuity of ejaculatory dysfunction
BJU International, 10/29/09
Relevance Score: 87%
Today in CV/Thromboembolic...keeping you current
Receive free subspecialty "5-minute updates" via email
The clinical course of pulmonary embolism patients anticoagulated for 1 year: results of a prospective, observational, cohort study
Journal of Thrombosis and Haemostasis, 12/18/09
Volumetric or time-based capnography for excluding pulmonary embolism in outpatients
Journal of Thrombosis and Haemostasis, 12/18/09
Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil
Rheumatology, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor